Shares of Advanced Cell Technology Inc. (OTC: ACTC), a biotechnology company engaged in the development and commercialization of human embryonic and adult stem cell technology in the emerging field of regenerative medicine, are climbing in trading today. At last check, ACTC shares were trading 10.94% higher at $0.0720 on above average volume of 29.50 million. The stock hit an intra-day high of $0.08.